NPM1 and acute myeloid leukemia: At present, there exists a clear consensus on numerous molecular abnormalities associated with AML prognosis such as NPM1 and FLT3 mutations [4,5]; thus, identifying novel prognostic genes has become pivotal in determining risk factors for AML.